These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15040759)

  • 1. Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.
    Bernardo JF; McCauley J
    Drugs Aging; 2004; 21(5):323-48. PubMed ID: 15040759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy in haemodialysis patients. Special considerations in the elderly.
    St Peter WL; Clark JL; Levos OM
    Drugs Aging; 1998 Jun; 12(6):441-59. PubMed ID: 9638393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
    Staatz CE; Tett SE
    Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?
    Meier-Kriesche HU; Kaplan B
    Drugs Aging; 2001; 18(10):751-9. PubMed ID: 11735622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Branch KR; McGrory CH; Coscia LA
    Clin Transpl; 1997; ():101-12. PubMed ID: 9919394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
    del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
    Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is age associated with the number or types of medications prescribed to renal transplant recipients?
    Chisholm MA; Melroy J; Johnson M; Mulloy LL; Spivey CA
    J Am Geriatr Soc; 2007 Mar; 55(3):389-94. PubMed ID: 17341241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
    Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P
    Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout in solid organ transplantation: a challenging clinical problem.
    Stamp L; Searle M; O'Donnell J; Chapman P
    Drugs; 2005; 65(18):2593-611. PubMed ID: 16392875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant diabetes mellitus: risk reduction strategies in the elderly.
    Duclos A; Flechner LM; Faiman C; Flechner SM
    Drugs Aging; 2006; 23(10):781-93. PubMed ID: 17067182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care of Transplant Recipients in Primary Practice.
    Brown DP; Chapman JR
    Transplantation; 2016 Mar; 100(3):474-6. PubMed ID: 26900807
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac operations in solid-organ transplant recipients.
    Mitruka SN; Griffith BP; Kormos RL; Hattler BG; Pigula FA; Shapiro R; Fung JJ; Pham SM
    Ann Thorac Surg; 1997 Nov; 64(5):1270-8. PubMed ID: 9386690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal disease in recipients of nonrenal solid organ transplantation.
    Ojo AO
    Semin Nephrol; 2007 Jul; 27(4):498-507. PubMed ID: 17616280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of immunosuppressive agents therapy in transplant patients.
    Reske A; Reske A; Metze M
    Minerva Anestesiol; 2015 Nov; 81(11):1244-61. PubMed ID: 25251864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients.
    Sigel K; Veluswamy R; Krauskopf K; Mehrotra A; Mhango G; Sigel C; Wisnivesky J
    Transplantation; 2015 Oct; 99(10):2181-9. PubMed ID: 25839704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipients.
    Shi YY; Hesselink DA; van Gelder T
    Transplant Rev (Orlando); 2015 Oct; 29(4):224-30. PubMed ID: 26048322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.